Breaking News: Updates in Treatments for TNBC
Join us to learn about the latest treatment updates for triple-negative breast cancer, for both early-stage and metastatic disease. We will cover the PARP inhibitors recently approved by the FDA, as well as other therapies in the pipeline. During this free webinar, you will learn what those treatments could mean for you, what information you need to make treatment decisions and how to discuss your options with your healthcare provider.
This webinar will begin with a 30- minute discussion with Rita Nanda, MD, about triple-negative breast cancer treatments for today and tomorrow. The remaining 30 minutes will be an interactive Q&A for participant comments and questions.
About Our Speaker:
Rita Nanda, MD
Rita Nanda, MD, is an associate professor of medicine and co-director of the breast medical oncology program at The University of Chicago. Dr. Nanda’s research interests include identifying new treatments for breast cancer, with a focus on triple-negative disease. Read more...